WednesdayJul 21, 2021 11:06 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Establishes New Subsidiary, Provides Update on Anticipated Acquisition

Pressure BioSciences (OTCQB: PBIO) has established a wholly owned agrochemicals subsidiary; the subsidiary will be named PBI Agrochem Inc. and is designed to house the announced asset acquisition from Global Agrochemicals Innovator. PBIO previously announced the acquisition of Global Agrochemicals Innovator, a global developer and supplier of environmentally responsible and organically natural agrochemicals, and anticipates completing that transaction in the coming weeks. In addition, PBIO announced that it has purchased specialized, proprietary material worth more than $500,000 to be used to fulfill initial demand for its ecofriendly, agrochemical pest control and growth stimulant products. "We have developed a very aggressive…

Continue Reading

MondayJul 19, 2021 10:14 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured in Recent Stock Day Podcast Discussing CBD Nanoemulsion Milestones

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, was featured in a recent episode of the Stock Day podcast. In the podcast, PBIO president and CEO Richard Schumacher the company’s recent nanoemulsion achievements with podcast host Everett Jolly. During the interview, Schumacher stated that the company recently transformed the potent antioxidant astaxanthin into a water-soluble compound, noting that astaxanthin, the most powerful nutritional antioxidant known to humans, is in short supply and is not easy to obtain. The substance is extracted from algae…

Continue Reading

WednesdayJul 14, 2021 12:54 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) UST(TM) CEO Featured on Benzinga’s Internationally Acclaimed Power Hour Luncheon

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology and other industries. The company has announced that its founder, president and CEO Ric Schumacher appeared as an invited guest on Tuesday, July 13, on the internationally acclaimed Power Hour luncheon hosted by Benzinga. Schumacher joined the podcast interview to provide a short overview of the company as well as to discuss two exciting announcements that PBI released over the past week. The announcements covered Pressure BioSciences’ Ultra Shear Technology- ("UST") enabled nanoemulsions…

Continue Reading

TuesdayJul 13, 2021 9:00 am

Powerful Antioxidant Nanoemulsion Development Lights Up the Profile of Pressure BioSciences Inc. (PBIO)

Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) specializes in the use of ultra-high pressure technologies to innovate unexpected and potent solutions for a wide variety of industries, including biomarker and target discovery, forensics, counter-bioterror applications, improved quality and economics for biopharmaceuticals, and safer, more potent and more cost-effective, storage, dosing and absorption of nutrients, nutraceuticals, cosmeceuticals, agrochemicals for plants, and more Pressure BioSciences recently announced the development of extraordinarily effective dosing and delivery in uniform nanoemulsions of 30 to 60 nm droplets for the powerful antioxidant astaxanthin (“AsX”), and suitable for many other prospective nutraceuticals PBIO’s technology for nanoemulsions…

Continue Reading

ThursdayJul 01, 2021 1:58 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UST(TM) Platform Delivers Breakthrough Results Processing One of the Most Powerful Antioxidants Known to Science

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology and other industries, today announced the successful application of its Ultra Shear Technology(TM) (“UST(TM)”) platform. According to the update, the novel UST platform was used for the development of more potent formulations of wide-ranging nutraceuticals of high therapeutic value, allowing for more controlled dosing and opportunities for lower cost solutions for both manufacturers and consumers. Specifically, PBI reported breakthrough results in processing one of the most powerful antioxidants known to science, astaxanthin (“AsX”), in…

Continue Reading

WednesdayJun 23, 2021 12:26 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present, Share Highlights at Emerging Growth Conference

Pressure BioSciences (OTCQB: PBIO) has announced its CEO will be participating in the upcoming Emerging Growth Conference. PBIO is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services to the worldwide life sciences, agriculture, food & beverage, and other key industries. Slated for June 23, the real-time, interactive investor conference has scheduled 10 companies to present for 30-45 minutes each; PBIO will be one of those companies. PBIO president and CEO Richard T. Schumacher will represent the company. His presentation, which is scheduled to start at 1:30 p.m. ET, will feature a corporate…

Continue Reading

TuesdayJun 08, 2021 2:01 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at LD Micro Virtual Invitational Conference XI

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences and other industries, today announced its participation in the upcoming LD Micro Virtual Invitational Conference XI. The three-day, virtual investor conference will feature approximately 180 companies, presenting for 25 minutes each, as well as several influential keynotes. PBI's president and CEO Richard T. Schumacher will present a corporate overview, including a discussion of PBI’s resurgent revenue growth in 2021, the potential impact of the anticipated commercial release of its revolutionary Ultra Shear…

Continue Reading

WednesdayMay 19, 2021 9:30 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Resurgent Growth, Strong Q1 2021 Results

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other industries, today announced its best financial results in nearly three years for the first quarter ended March 31, 2021. Among the highlights, the company reported a 121% increase in total revenue for Q1 2021 to $559,900 compared to $253,900 for Q1 2020. “We had a remarkable first quarter. Sales increased across the board — in instruments, consumables and kits. Importantly, we saw a concomitant decline in operating loss,” said Richard T.…

Continue Reading

TuesdayMay 18, 2021 9:15 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Teleconference to Discuss Q1 2021 Results, Provide Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced that it will host a teleconference to discuss its first quarter 2021 financial results and provide a business update. The teleconference is scheduled to begin at 4:30 p.m. Eastern Time on Wednesday, May 19, 2021. Interested parties may join the live teleconference by dialing (877)-407-8033 (North America) or 201-689-8033 (International) and stating verbal passcode: PBI Q1 2021 Financial Call and Business Update. For those unable to participate in the live teleconference, a…

Continue Reading

ThursdayMay 13, 2021 10:15 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Additional Patents for Revolutionary UST(TM) Platform

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced the award of three additional patents for its revolutionary Ultra Shear Technology(TM) (“UST(TM)”) platform, all entitled “System for High Pressure, High Shear Processing of Fluids.” According to the update, the new patents, awarded in Japan (No. 6843063), Australia (No. 2016243553) and China (ZL201680026865.2), bring the company's intellectual property (“IP”) estate to a total of six issued patents for UST and 29 issued patents overall. “Nanoemulsions of ingestible, topical and other products have…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered